Article Sidebar
Views PDF: 345
WHITE-COAT HYPERTENSION AND MASKED HYPERTENSION IN DIABETIC TYPE 2 PATIENTS: PREVALENCE AND THEIR RELATED FACTORS
Main Article Content
Abstract
Introduction: Hypertension is the most common comorbidity of diabetes. White-coat and masked hypertension are high prevalence hypertension phenotypes, especially in type 2 diabetic patients. Objectives: To evaluate the prevalence and related factors of white-coat and masked hypertension in type 2 diabetic patients. Method: A cross-sectional study was conducted in 306 diabetic type 2 patients in Nhan Dan Gia Dinh hospital – Ho Chi Minh city. Results: The prevalence of white-coat and masked hypertension were 30.1% and 24.5%, respectively. Age, family history of hypertension, diabetes, smoking, drinking, salt consuming, and physical activites were associated with hypertension phenotypes. Conclusion: Data remind us of application ambulatory blood pressure monitoring to identify hypertension phenotypes for prevention adverse events in type 2 diabeticsubjects.
Article Details
Keywords
White-coat hypertension, masked hypertension, diabetes type 2, related factors
References
2. Võ Thị Hà Hoa, Đặng Văn Trí (2013) "Khảo sát đặc điểm biến thiên huyết áp ở bệnh nhân tăng huyết áp ẩn giấu qua Holter huyết áp 24 giờ". Tạp chí Y học Tp.Hồ Chí Minh, 17 (3), tr.218-224
3. Gorostidi M, de la Sierra A, González-Albarrán O, Segura J, de la Cruz JJ, Vinyoles E, Llisterri JL, Aranda P, Ruilope LM, Banegas JR (2011) "Abnormalities in ambulatory blood pressure monitoring in hypertensive patients with diabetes". Hypertens Res, 34 (11), pp.1185-9
4. Leiria LF, Severo MD, Ledur PS, Becker AD, Aguiar FM, Massierer D, Freitas VC, Schaan BD, Gus M (2015) “White coat effect and masked uncontrolled hypertension in treated hypertensive-diabetic patients: Prevalence and target organ damage”. Journal of diabetes, 7 (5), pp.699–707.
5. Mancia G, De Backer G, Dominiczak A, et al (2007) "2007 Guidelines for the management of arterial hypertension The Task Force for the Management of Arterial Hypertension of the European Sociaty of Hypertension (ESH) and of the European Society of Cardiology(ESC)". European Heart Journal, 28, pp.1462-1536.
6. Mazze RS, Robinson R, Simonson G, Idrogo M, Simpson B, Kendall D, Bergenstal R (2004) “Undetected, uncontrolled blood pressure in type 2 diabetes: self-monitored blood pressure profiles”. Blood Press, 13, pp.335-42.
7. Tomiyama M, Horio T, Yoshii M, Takiuchi S, Kamide K, Nakamura S, Yoshihara F, Nakahama H, Inenaga T, Kawano Y (2006) "Masked hypertension and target organ damage in treated hypertensive patients". Am J Hypertens, 19 (9), pp.880-6.